Review of serious adverse events following yellow fever vaccination

New recommendations for clinical practice with strengthened measures to minimise the risk of serious and fatal reactions post vaccination are published
Review of serious adverse events following yellow fever vaccination

On 21 November 2019, the Medicines and Healthcare Regulatory Agency (MHRA), Public Health England (PHE), the National Travel Health Network and Centre and Health Protection Scotland (HPS) circulated a joint letter to inform health professionals of the recommendations of a Commission on Human Medicines (CHM) review of serious and fatal reactions following administration of yellow fever vaccine. The CHM found the balance between benefits and risks of yellow fever vaccine remains favourable for most travellers when used as indicated, but updated its recommendations to minimise risks to vaccinees. The recommendations aim to strengthen measures to minimise risk in those with weakened immune systems, for those aged 60 years or older, and anyone who has had their thymus removed to ensure that only those at significant and unavoidable risk of yellow fever are offered the vaccine.

The letter contains specific recommendations, and is available from this link. It will also be disseminated through alternative resources. 

Yellow Fever Vaccination Centres will receive a direct email from NaTHNaC on this issue. 

NaTHNaC will update their clinical resources in due course.


Search by


Explore more

Celebrating Diwali abroad?

Reduce your risk of injury and illness while celebrating Diwali by following our travel health advice

Updated: 12 November 2026

Help us to adapt a Travel Health Resource for UK Travellers

Take part in a study that aims to help UK travellers make informed choices about Japanese encephalitis (JE) vaccination

Updated: 26 October 2026

Heading to the Youth Olympic Games in Senegal, West Africa, this autumn?

Make sure you are protected – get the right travel advice, vaccines and malarial tablets before you travel!

Updated: 12 November 2026

Updated dengue 'green book' chapter published

The dengue chapter of the 'green book' (Immunisation against infectious disease) has been updated

Updated: 18 November 2026

Mefloquine shortage

Shortage of 250mg mefloquine (Lariam) antimalarial tablets in the United Kingdom (UK) continues

Updated: 09 September 2026